| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $6.3M | — | +85.9% |
| Cost of Revenue | $4.3M | — | +41.3% |
| Gross Profit | $1.9M | — | +526.1% |
| R&D Expense | $22.8M | — | +5.8% |
| SG&A Expense | $12.4M | — | +71.2% |
| Operating Income | -$35.1M | — | -15.5% |
| Interest Expense | $1.2M | — | — |
| Pre-tax Income | -$34.9M | — | -0.4% |
| Income Tax | $32K | — | -43.9% |
| Net Income | -$35.0M | — | -0.3% |
| EPS (Basic) | -$0.56 | — | +12.5% |
| EPS (Diluted) | -$0.56 | — | +12.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $31.2M | -56.9% | +47.0% |
| Short-term Investments | $68.3M | +37.7% | +14.3% |
| Accounts Receivable | $3.5M | +2.7% | +345.7% |
| Inventory | $6.0M | +3.4% | +54.1% |
| Current Assets | $122.1M | -20.5% | +33.0% |
| Total Assets | $147.3M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$25.8M | — | +16.1% |
| Capital Expenditures | $2.2M | — | +384.7% |
| Investing Cash Flow | -$20.5M | — | -187.8% |
| Financing Cash Flow | $5.2M | — | +2951.9% |
| Free Cash Flow | -$28.1M | — | +10.2% |
| +28.6% |
| Current Liabilities | $29.8M | -16.9% | -6.5% |
| Total Liabilities | $159.7M | -4.1% | +249.2% |
| Stockholders' Equity | -$12.4M | -193.9% | -118.0% |